AID Life Science Holdings Limited provided group earnings guidance for the year ended December 31, 2020. For the year, the group expects to record a 30% to 40% increase in loss as compared to the loss of approximately HKD 149.7 million for the year ended December 31, 2019. The increase in loss was mainly attributable to the increase in fair value losses on financial assets at fair value through profit or loss during the year.